Mazzarotto, Francesco
 Distribuzione geografica
Continente #
AS - Asia 1.225
NA - Nord America 1.141
EU - Europa 485
SA - Sud America 356
AF - Africa 45
OC - Oceania 5
Totale 3.257
Nazione #
US - Stati Uniti d'America 1.085
SG - Singapore 476
BR - Brasile 295
CN - Cina 246
HK - Hong Kong 183
VN - Vietnam 122
IT - Italia 81
FR - Francia 73
DE - Germania 67
GB - Regno Unito 67
TR - Turchia 62
IE - Irlanda 45
RU - Federazione Russa 42
IN - India 33
FI - Finlandia 28
CA - Canada 27
AT - Austria 25
BD - Bangladesh 24
AR - Argentina 22
MX - Messico 17
ZA - Sudafrica 13
EC - Ecuador 12
IQ - Iraq 12
SE - Svezia 12
PK - Pakistan 11
CO - Colombia 10
JP - Giappone 9
MA - Marocco 8
ES - Italia 7
UA - Ucraina 7
VE - Venezuela 7
EG - Egitto 6
PL - Polonia 6
UZ - Uzbekistan 6
AE - Emirati Arabi Uniti 5
AU - Australia 5
DZ - Algeria 5
SA - Arabia Saudita 5
CZ - Repubblica Ceca 4
ID - Indonesia 4
LT - Lituania 4
TH - Thailandia 4
AZ - Azerbaigian 3
BO - Bolivia 3
CH - Svizzera 3
GT - Guatemala 3
HN - Honduras 3
KR - Corea 3
PY - Paraguay 3
SY - Repubblica araba siriana 3
AL - Albania 2
BE - Belgio 2
CR - Costa Rica 2
ET - Etiopia 2
IR - Iran 2
JM - Giamaica 2
JO - Giordania 2
KE - Kenya 2
KH - Cambogia 2
NG - Nigeria 2
NL - Olanda 2
UY - Uruguay 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BG - Bulgaria 1
CG - Congo 1
CI - Costa d'Avorio 1
CL - Cile 1
DK - Danimarca 1
EE - Estonia 1
GY - Guiana 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
MU - Mauritius 1
NO - Norvegia 1
PH - Filippine 1
PS - Palestinian Territory 1
PT - Portogallo 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SV - El Salvador 1
TJ - Tagikistan 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 3.257
Città #
Singapore 244
Hong Kong 183
Ashburn 123
San Jose 105
The Dalles 98
Princeton 82
Lauterbourg 57
Los Angeles 51
Fairfield 50
Istanbul 47
Beijing 46
Dublin 43
Ho Chi Minh City 41
Houston 32
São Paulo 30
Helsinki 28
Hanoi 25
Redondo Beach 25
San Diego 24
New York 21
Seattle 21
Dallas 20
San Francisco 20
Wilmington 19
Moscow 18
Nuremberg 16
Des Moines 14
Orem 14
Villa Carcina 14
Belo Horizonte 13
Brescia 13
London 13
Toronto 13
Ann Arbor 12
Buffalo 12
Council Bluffs 12
Vienna 12
Woodbridge 12
Cambridge 10
Atlanta 9
Düsseldorf 9
Milan 9
Pontassieve 9
Stockholm 9
Guangzhou 8
Munich 8
Santa Clara 8
Tokyo 8
Chennai 7
Chicago 7
Curitiba 7
Dhaka 7
Manchester 7
Tianjin 7
Baghdad 6
Brasília 6
Denver 6
Montreal 6
Mumbai 6
Portsmouth 6
Quito 6
Tashkent 6
Bremen 5
Brooklyn 5
Frankfurt am Main 5
Haiphong 5
Hải Dương 5
Johannesburg 5
Kyiv 5
Melbourne 5
Rio de Janeiro 5
Romola 5
Shanghai 5
Thái Bình 5
Biên Hòa 4
Boston 4
Charlotte 4
Fortaleza 4
Goiânia 4
Kilburn 4
Lahore 4
Mantova 4
Mexico City 4
Phoenix 4
Poplar 4
Sheffield 4
Uberlândia 4
Warsaw 4
Algiers 3
Ankara 3
Boardman 3
Bogotá 3
Buenos Aires 3
Caracas 3
Caxias do Sul 3
Chiswick 3
City of London 3
Da Nang 3
Duque de Caxias 3
Elk Grove Village 3
Totale 1.952
Nome #
Genome-wide association testing beyond SNPs 127
Comparison of long-term outcome in anthracycline-related versus idiopathic dilated cardiomyopathy: a single centre experience 86
Ion channel dysfunction and fibrosis in atrial fibrillation: Two sides of the same coin 81
Comprehensive sequencing of dilated cardiomyopathy genes reveals additive effects of multiple genes on disease risk and severity 80
Advantages and Perils of Clinical Whole-Exome and Whole-Genome Sequencing in Cardiomyopathy 80
Evaluation of gene validity for CPVT and short QT syndrome in sudden arrhythmic death 80
Disease Progression of Hypertrophic Cardiomyopathy: Modeling Using Machine Learning 76
Genetic determinants of coping, resilience and self-esteem in schizophrenia suggest a primary role for social factors and hippocampal neurogenesis 75
Integrated allelic, transcriptional, and phenomic dissection of the cardiac effects of titin truncations in health and disease 75
Defining the diagnostic effectiveness of genes for inclusion in panels: the experience of two decades of genetic testing for hypertrophic cardiomyopathy at a single center 74
A gene-centric strategy for identifying disease-causing rare variants in dilated cardiomyopathy 72
Shared Genetic Predisposition in Peripartum and Dilated Cardiomyopathies 71
Reevaluating the Genetic Contribution of Monogenic Dilated Cardiomyopathy 71
Investigation on the high recurrence of the ATTRv-causing transthyretin variant Val142Ile in central Italy 70
Enhancing rare variant interpretation in inherited arrhythmias through quantitative analysis of consortium disease cohorts and population controls 69
Comprehensive Assessment of Rare Genetic Variation in Dilated Cardiomyopathy Genes in Patients and Controls (vol 101, pg A41, 2015) 67
Systematic large-scale assessment of the genetic architecture of left ventricular noncompaction reveals diverse etiologies 67
Evidence-Based Assessment of Genes in Dilated Cardiomyopathy 67
Shared genetic pathways contribute to risk of hypertrophic and dilated cardiomyopathies with opposite directions of effect 67
Temporal Trend of Age at Diagnosis in Hypertrophic Cardiomyopathy: An Analysis of the International Sarcomeric Human Cardiomyopathy Registry 66
EFFECTS OF TRUNCATING VARIANTS IN TITIN ON CARDIAC PHENOTYPE AND LEFT VENTRICULAR REMODELLING IN DILATED CARDIOMYOPATHY 65
Ion channel dysfunction and fubrosis in atrial fibrillation:Two sides of the same coin 64
CLINICAL AND GENETIC CHARACTERISTICS OF FAMILIAL DILATED CARDIOMYOPATHY IN A LARGE UK PROSPECTIVE COHORT 64
Quantifying evidence toward pathogenicity for rare phenotypes: the case of succinate dehydrogenase genes, SDHB and SDHD 63
Exploring the complex spectrum of dominance and recessiveness in genetic cardiomyopathies 60
Allele-specific expression analysis: pipelines, applications, challenges, and unmet needs 60
Calcium handling maturation and adaptation to increased substrate stiffness in human iPSC-derived cardiomyocytes: The impact of full-length dystrophin deficiency 60
Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples 59
Sex-related differences in exercise performance and outcome of patients with hypertrophic cardiomyopathy 58
A machine learning-based risk stratification model for ventricular tachycardia and heart failure in hypertrophic cardiomyopathy 58
ZBTB17 (MIZ1) Is Important for the Cardiac Stress Response and a Novel Candidate Gene for Cardiomyopathy and Heart Failure 57
FineSplice, enhanced splice junction detection and quantification: a novel pipeline based on the assessment of diverse RNA-Seq alignment solutions 56
Contemporary Insights Into the Genetics of Hypertrophic Cardiomyopathy: Toward a New Era in Clinical Testing? 55
Disease-specific variant pathogenicity prediction significantly improves variant interpretation in inherited cardiac conditions 55
Arrhythmogenic potential of myocardial disarray in hypertrophic cardiomyopathy: genetic basis, functional consequences and relation to sudden cardiac death 55
Quantitative approaches to variant classification increase the yield and precision of genetic testing in Mendelian diseases: the case of hypertrophic cardiomyopathy 55
Comparison of long-term clinical course and outcome of MYBPC3-versus MYH7-related hypertrophic cardiomyopathy 54
Spatial and Functional Distribution of MYBPC3 Pathogenic Variants and Clinical Outcomes in Patients with Hypertrophic Cardiomyopathy 53
Genetic and Phenotypic Characterization of Nexilin (NEXN)–Related Cardiomyopathy 52
Computational prediction of protein subdomain stability in MYBPC3 enables clinical risk stratification in hypertrophic cardiomyopathy and enhances variant interpretation 52
INTEGRATED ALLELIC, TRANSCRIPTIONAL, AND PHENOTYPIC DISSECTION OF THE CARDIAC EFFECTS OF TITIN VARIATION IN HEALTH AND DISEASE 52
Two decades of genetic testing in hypertrophic cardiomyopathy in a single center: The additive value of extended next-generation sequencing panels lies in the early diagnosis of metabolic mimics 51
Titin-truncating variants affect heart function in disease cohorts and the general population 51
Temporal Trend in Age at Diagnosis of Hypertrophic Cardiomyopathy: An Analysis of the Share Registry 50
Quantitative approaches to variant classification increase the yield and precision of genetic testing in Mendelian diseases 50
Genetic ancestry analysis of the Italian founder population carrying the cardiac amyloidosis-causing variant Val122Ile in the transthyretin gene 49
Large-scale genome-wide association analyses identify novel genetic loci and mechanisms in hypertrophic cardiomyopathy 49
Re-evaluating the genetic contribution of monogenic dilated cardiomyopathy 48
Temporal trend in age at diagnosis of hypertrophic cardiomyopathy: an analysis of the share registry 48
Phenotypic Expression and Outcomes in Individuals With Rare Genetic Variants of Hypertrophic Cardiomyopathy 48
RE-EVALUATING THE GENETIC CONTRIBUTION OF MONOGENIC DILATED CARDIOMYOPATHY 43
Slower Calcium Handling Balances Faster Cross-Bridge Cycling in Human MYBPC3 HCM 42
Long-Term Prevalence of Systolic Dysfunction in MYBPC3 Versus MYH7-Related Hypertrophic Cardiomyopathy 37
Allele-specific expression analysis: pipelines, applications, challenges, and unmet needs 28
Totale 3.322
Categoria #
all - tutte 25.816
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.816


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022330 127 16 2 6 0 18 46 8 13 2 13 79
2022/2023107 41 0 1 4 1 42 2 0 6 9 1 0
2023/2024201 1 2 15 15 5 5 5 4 99 2 0 48
2024/2025845 1 6 6 85 88 49 71 84 80 97 183 95
2025/20261.839 191 266 155 322 174 128 273 104 137 89 0 0
Totale 3.322